4.7 Review

The Promise and Perils of Stem Cell Therapeutics

期刊

CELL STEM CELL
卷 10, 期 6, 页码 740-749

出版社

CELL PRESS
DOI: 10.1016/j.stem.2012.05.010

关键词

-

资金

  1. NIH [R24DK092760, UO1-HL100001, RC4-DK090913, P50HG005550]
  2. ARRA [RC2-HL102815]
  3. Roche Foundation for Anemia Research
  4. Alex's Lemonade Stand
  5. Ellison Medical Foundation
  6. Doris Duke Medical Foundation
  7. Harvard Stem Cell Institute

向作者/读者索取更多资源

Stem cells are the seeds of tissue repair and regeneration and a promising source for novel therapies. However, apart from hematopoietic stem cell (HSC) transplantation, essentially all other stem cell treatments remain experimental. High hopes have inspired numerous clinical trials, but it has been difficult to obtain unequivocal evidence for robust clinical benefit. In recent years, unproven therapies have been widely practiced outside the standard clinical trial network, threatening the cause of legitimate clinical investigation. Numerous challenges and technical barriers must be overcome before novel stem cell therapies can achieve meaningful clinical impact.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据